Hydroxycarbamide in very young children with sickle-cell anaemia: a multicentre, randomised, controlled trial (BABY HUG)
W.C. Wang1, R.E. Ware1, S.T. Miller2, R.V. Iyer3, J.F. Casella4, C.P. Minniti5, S. Rana6, C.D. Thornburg7, Z.R. Rogers8, R.V. Kalpatthi9, J.C. Barredo10, R.C. Brown11, S.A. Sarnaik12, T.H. Howard13, L.W. Wynn1, A. Kutlar14, F.D. Armstrong10, B.A. Files11, J.C. Goldsmith15, M.A. Waclawiw15, X. Huang16, B.W. Thompson16, BABY HUG investigators
1 St. Jude Children’s Research Hospital
2 SUNY Downstate Medical Center
3 University of Mississippi Medical Center
4 Johns Hopkins University School of Medicine
5 Children’s National Medical Center
6 Howard University College of Medicine
7 Duke University Medical Center
8 University of Texas Southwestern Medical Center, Dallas
9 Medical University of South Carolina
10 University of Miami
11 Emory University School of Medicine
12 Children’s Hospital of Michigan
13 University of Alabama at Birmingham
14 Medical College of Georgia
15 National Heart, Lung and Blood Institute
16 the Clinical Trials and Surveys Corporation
The Lancet
Volume 377, Issue 9778, 14 May 2011, Pages 1663-1672